Global Pharmaceutical Anti-Counterfeiting Technologies Market showed crucial growth in the recent years and is anticipated to witness a steep rise by generating an estimated revenue of US$ xx.xx billion over the forecast period. According to latest study conducted by our analysts and industry experts, the global market is expected to grow at a CAGR of xx.xx% during the forecast period that is 2017-2025. Pharmaceutical products are the most exposed goods for counterfeiting practices across the globe. Various counterfeiting practices involve replacement of original drug with low quality drug, which contains toxic substances or no active ingredient. These technologies are mainly applied to reduce the adverse impact on the patients’ health, which may lead to death if ignored.

Global Market Growth Opportunities (Revenue, Growth) By 2017-2025

This global market study report analysis offers in-depth insights, revenue details, and other vital information regarding the global pharmaceutical anti-counterfeiting technologies market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2025. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global pharmaceutical anti-counterfeiting technologies market report has been segmented on the basis of type, application, and region. It includes the estimation of the market size, in terms of value, with respect to 4 main geographies, namely, North America, Europe, APAC, and RoW.    

Market Dynamics

Pharmaceutical anti-counterfeiting technologies market is primarily driven by the growing incidences of counterfeiting medicines, which are further affecting the total human capital and also patients’ health. According to the International Trade Administration, in 2016, the global value for counterfeited drugs was valued in between US$ 75 - 200 billion, which acts as a serious threat to the people’s health worldwide. In 2017, according to a report by the Pharmaceutical Security Institute (PSI), there is a significant rise in drug diversion incidents across the world, which might include the diversion of drugs marketed for compassionate use also. Moreover, the use of duplicate drugs might cause several health issues, or eventual death of the patients. This would significantly propel the growth of pharmaceutical anti-counterfeiting technologies market over the projected period.

By Technology Insights: The global pharmaceutical anti-counterfeiting technologies market is expected to be dominated by bar codes segment. Some key drivers responsible for its dominant market share include high market penetration rates for use in various kinds of drugs, especially relating to the product packaging, along with inventory management facets and high traceability and accuracy features.

Regional Analysis

The global pharmaceutical anti-counterfeiting technologies market is divided into regions that are North America - U.S, Canada, Other; Asia-Pacific -India, Japan, China, Australia, Other; Europe - UK, Russia, France, Brazil, Other; Middle East and Africa. Every region analysis details in sense of growth, revenue, volume, challenges, and opportunities with the regional and global key players. North America pharmaceutical anti-counterfeiting technologies market is predicted to dominate the global market over the projected period. This is majorly attributed by the huge presence of sophisticated healthcare infrastructure, which is easing the implementation of this kind of technologies. Moreover, the implementations of strict regulations by the regulatory bodies such as the FDA are some of the key drivers helping the growth of the North America pharmaceutical anti-counterfeiting technologies market.

Asia Pacific pharmaceutical anti-counterfeiting technologies market is expected to grow at a prime CAGR during the forecast period, majorly owing to the high presence of counterfeit products, particularly in developing economies such as China and India. Moreover, rapidly developing healthcare infrastructure in these countries will significantly enhance the market growth. Middle East and Africa held the measurable growth in the global market in 2018 and will expand at the significant CAGR during the forecast years.    

Global Pharmaceutical Anti-Counterfeiting Technologies Market Study Objective

1. To forecast the market size of pharmaceutical anti-counterfeiting technologies market, along with describing and defining the market, in terms of volume and revenue as well as market opportunities for stakeholders, in order to provide a competitive landscape for global market players.

2. Market analysis and forecast of pharmaceutical anti-counterfeiting technologies market on the basis of region, substrate and application or end-use industry. To profile major market players, and to analyze their market shares and essential competencies comprehensively.

3. To analyze and elaborate significant factors that will have major impact on the growth of pharmaceutical anti-counterfeiting technologies market, such as drivers, restraints, challenges and opportunities.

4. Regional analysis of pharmaceutical anti-counterfeiting technologies market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa and Asia Pacific.

5. Strategic analysis of micromarkets, in terms of individual prospects, opportunities, growth trends and their involvement in overall market.

6. To provide detailed analysis of competitive and strategic developments in the pharmaceutical anti-counterfeiting technologies market like new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.

Key Players Landscape

Some key players in the pharmaceutical anti-counterfeiting technologies market include Alien Technology, 3M Company, Angstrom Technologies, Alpvision, Authentix, Inc., ThermoFisher Scientific, Colorcon, Avery Dennison Corporation, Everest Holovisions Ltd., and Covectra among several others. Key players in this market are adopting several strategic collaborations with their competitors to enhance their market positions. Moreover, they are also launching several new products, in order to retain their market position. For instance, Daily Wellness Company opted TruTag’s platform for its health products and nutraceuticals segment, in which the company’s various products will be tagged, in order to allow authentication and detection throughout the value chain. This company joined forces with Sumitomo Corporation in the U.S. to invest in developing its technology for the pharmaceutical end-use industry. In May 2017, Alien Technology launched its ALR-F800-X along with Emissary, which is expected to simplify the RFID reader installation, infrastructure, maintenance, and operations.

Global Pharmaceutical Anti-Counterfeiting Technologies Market Study Report Offer You!

The global market study report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast. The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.